Home › Pagkabigo ng Bato › Tennessee
Pag-aaral pangklinika para sa Pagkabigo ng Bato sa Tennessee
7 pag-aaral para sa Pagkabigo ng Bato ang naghahanap ng mga kalahok sa mga site sa Tennessee.
Mga Lungsod sa Tennessee
Opisyal na teksto ng pag-aaral (English)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Southeast Renal Research Institute, Chattanooga
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
- at 2 pa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- Memphis VA Medical Center, Memphis, TN, Memphis
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05465044Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- Vascular Institute of Chattanooga, Chattanooga
- Bluff City Vascular, Memphis
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT04634916Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
- Nephrology Associates of Knoxville, Knoxville
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06613568Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
- Galen Medical Group, Chattanooga
Nagre-recruit
Edad 18 hanggang 84 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06190717SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- James Eric Gardner, MD, PC, Memphis
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT06001827CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
- Vanderbilt University Medical Center-GCRC, Nashville
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ene 2, 2026 · NCT05422534Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.